TRACON Pharmaceuticals Financials
Based on the key indicators related to TRACON Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, TRACON Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.
With this module, you can analyze TRACON financials for your investing period. You should be able to track the changes in TRACON Pharmaceuticals individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
TRACON |
The data published in TRACON Pharmaceuticals' official financial statements typically reflect TRACON Pharmaceuticals' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving TRACON Pharmaceuticals' quantitative information. For example, before you start analyzing numbers published by TRACON accountants, it's essential to understand TRACON Pharmaceuticals' liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.
TRACON Pharmaceuticals Stock Summary
TRACON Pharmaceuticals competes with Rezolute, XOMA Corp, Vincerx Pharma, Entera Bio, and Tempest Therapeutics. TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California. Tracon Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.Specialization | Healthcare, Biotechnology |
Instrument | USA OTC Stock View All |
Exchange | OTCQB Exchange |
ISIN | US89237H2094 |
CUSIP | 89237H100 89237H209 89237H308 |
Location | California; U.S.A |
Business Address | 4350 La Jolla |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.traconpharma.com |
Phone | 858 550 0780 |
Currency | USD - US Dollar |
TRACON Pharmaceuticals Key Financial Ratios
TRACON Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from TRACON Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of TRACON Pharmaceuticals over time and compare it to other companies across industries.TRACON Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining TRACON Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare TRACON Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across TRACON Pharmaceuticals competition to find correlations between indicators driving TRACON Pharmaceuticals's intrinsic value. More Info.TRACON Pharmaceuticals is rated below average in return on equity category among its peers. It is rated second in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value TRACON Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for TRACON Pharmaceuticals' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in TRACON OTC Stock
If you are still planning to invest in TRACON Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TRACON Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |